0001384101-19-000108.txt : 20190814 0001384101-19-000108.hdr.sgml : 20190814 20190814161540 ACCESSION NUMBER: 0001384101-19-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190812 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kennedy Giulia C CENTRAL INDEX KEY: 0001769333 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 191026555 MAIL ADDRESS: STREET 1: 338 MAIN STREET #26E CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wf-form4_156581372426743.xml FORM 4 X0306 4 2019-08-12 0 0001384101 VERACYTE, INC. VCYT 0001769333 Kennedy Giulia C 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific & Med Officer Common Stock 2019-08-12 4 M 0 8243 10.45 A 56575 D Common Stock 2019-08-12 4 M 0 1667 8.86 A 58242 D Common Stock 2019-08-12 4 M 0 5000 6.45 A 63242 D Common Stock 2019-08-12 4 M 0 1563 5.43 A 64805 D Common Stock 2019-08-12 4 M 0 7083 9.05 A 71888 D Common Stock 2019-08-12 4 M 0 4406 5.98 A 76294 D Common Stock 2019-08-12 4 S 0 28257 25.3776 D 48037 D Common Stock 2019-08-13 4 M 0 4640 10.45 A 52677 D Common Stock 2019-08-13 4 S 0 4640 25.45 D 48037 D Stock Option (right to buy) 10.45 2019-08-12 4 M 0 8243 0 D 2024-09-15 Common Stock 8243.0 4642 D Stock Option (right to buy) 8.86 2019-08-12 4 M 0 1667 0 D 2025-03-01 Common Stock 1667.0 0 D Stock Option (right to buy) 6.45 2019-08-12 4 M 0 5000 0 D 2026-02-28 Common Stock 5000.0 11253 D Stock Option (right to buy) 5.43 2019-08-12 4 M 0 1563 0 D 2026-03-14 Common Stock 1563.0 5210 D Stock Option (right to buy) 9.05 2019-08-12 4 M 0 7083 0 D 2027-03-02 Common Stock 7083.0 37188 D Stock Option (right to buy) 5.98 2019-08-12 4 M 0 4406 0 D 2028-03-01 Common Stock 4406.0 48469 D Stock Option (right to buy) 10.45 2019-08-13 4 M 0 4640 0 D 2024-09-15 Common Stock 4640.0 2 D The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019. Represents weighted average sales price. Sale prices for the transactions range from $25.12 to $25.94. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. The option is fully vested. The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. The option became exercisable as to 25% of the shares on March 15, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. /s/ Keith Kennedy as attorney-in-fact 2019-08-14